Risk Management · 2024
In this section2 topics
Risk Management Policy & Plan
Main Introduction
The Company places importance on risk management to address risks that could affect the achievement of the Company's objectives and goals in conducting business. The Company has established a Risk Management Committee to oversee risk management within the Company, which comprises members of the Board of Directors, executives, and representatives from various departments. It is responsible for establishing policies, developing systems, and assessing various risks arising from both external factors and internal management and operations. It also defines guidelines for managing and mitigating risks to an acceptable level.
Policy & Plan Description
The Board recognizes the importance of risk management as it is considered a fundamental pillar of business administration. The risk management process, including risk identification, risk assessment, and regular risk monitoring and review, is a proactive management approach that the company must implement and practice.
The Board has appointed a Risk Management Committee, consisting of members from the Board of Directors and relevant key executives. Currently, there are 15 members on the Risk Management Committee. The company has adopted the COSO-ERM framework, which categorizes the components of an organization's risk management process into 8 components, as a framework for risk management. This ensures that business operations align with the goals of sustainable development.
1. Internal Environment is a fundamental component of enterprise risk management as it shapes the structure and work discipline. The internal environment influences how strategies and business objectives are set, how business activities are structured, and how risks are identified, assessed, and managed.
2. Objective Setting requires organizations to define their business objectives or goals before identifying potential risk events that could impact the achievement of those objectives or goals. These objectives must align with the organization's risk appetite.
3. Event Identification is the process of identifying potential risk events or uncertainties by considering both internal and external factors. External factors include economic conditions, technological changes, and the natural environment. Internal factors include personnel, processes, and technology.
4. Risk Assessment helps organizations understand how risk events or uncertainties might affect the achievement of their objectives. This involves analyzing two aspects: the likelihood of a risk event occurring (Likelihood) and the impact if it does occur (Impact).
5. Risk Response requires management to select risk management methods that bring assessed risks to a level acceptable to the organization. Risk management methods include risk avoidance, acceptance, reduction, and diversification.
6. Control Activities are policies and procedures that help ensure that the risk management methods defined in the previous steps are carried out correctly. Organizations must establish these control activities comprehensively across all levels and functions (All Functions).
7. Information & Communication must identify information from both internal and external sources and have a system to communicate it to personnel within the organization. This ensures they can perform their duties and responsibilities. Effective communication also encompasses top-down, bottom-up, and interdepartmental communication. According to COSO guidelines, information is crucial and necessary at all levels of the organization. We use information to identify, assess, and determine how to manage risks, as well as for other aspects of achieving our established goals.
8. Monitoring is essential to ensure the quality and appropriateness of risk management and that it is effectively controlled and managed. Monitoring includes risks, control activities, outcomes of activities, implementation timeframe, progress, problems, and obstacles. The following aspects are monitored:
1. Risk-exposed units regularly monitor, assess, analyze, and manage risks. The internal control system in place is adequate, appropriate, effective, implemented in practice, and yields tangible results. It can prevent or mitigate potential risks.
2. There are audits to recommend improvements to deficiencies in a timely manner.
3. Reporting risk management results to the risk management committee, senior management, and the audit committee.
Business Continuity Management
The company, through its risk management committee, has developed a business continuity plan to prepare for various events such as pandemics, natural disasters, terrorism, theft, or other unforeseen errors beyond our control. These events could potentially disrupt business operations. The business continuity plan helps mitigate damage and enables rapid business recovery, building confidence among business stakeholders.
Risks to the Company's Business Operations
Risk Register
| Risk Name | Risk Characteristics | Consequences | Management Measures | Related Risk Factors |
|---|---|---|---|---|
| Risks of Being a Medical Device and Equipment Distributor | The company operates as an exclusive distributor of medical instruments and equipment. It imports medical instruments and equipment from overseas manufacturers who are leading and well-known companies in the medical industry. The company distributes these products to customers domestically under the manufacturers' brands. The company has signed distributor agreements with the manufacturers, with contract durations ranging from 1 to 3 years. | The Company's lack of its own manufacturing facility poses a risk to its business as a distributor of medical instruments and medical equipment. If, in the future, the Company's Distributor Agreement is not renewed by the manufacturer, and/or the medical equipment manufacturer sells its products directly to customers, or the manufacturer terminates the Company's distributorship due to other competitors, or in the event that the Company is unable to comply with the terms of the Distributor Agreement with the manufacturer, such as the minimum purchase order requirements that the Company must purchase from the manufacturer, resulting in the manufacturer terminating the Company's distributorship, it could have an impact on the Company's revenue. | The Company focuses on selling products that it has determined to be products in which it has sales expertise. In addition, the Company's customer base consists mainly of government hospitals and leading private hospitals in Thailand. The nature of selling medical instruments and equipment in Thailand requires expertise in presenting products to customers. The Company has therefore gained trust as a distributor to sell quality products, coupled with excellent service that has impressed customers, thus building customer confidence. The Company has strengths as a distributor, including well-known and high-quality products that are recognized by customers, a sales team with knowledge and expertise in presenting products to customers, as well as sales skills. This has led the Company to gain trust in distributing products from manufacturers and to have its Distributor Agreements renewed continuously. In addition, if an event occurs that prevents the Company from achieving the minimum purchase order as specified in the Distributor Agreement, despite the Company's best efforts to sell the products, the Company will clarify the reasons for not being able to achieve the minimum purchase order and discuss with the manufacturer for mutual understanding. This will not result in the termination of the Distributor Agreement. With over 22 years of experience in business operations, the Company's management has been purchasing products from manufacturers for a long and continuous period. Coupled with extensive experience in sales and customer service, the Company is able to select high-quality medical instruments and equipment with production standards from reputable international manufacturers that are accepted by customers. The Company has therefore been recognized and appointed as a distributor of a wide variety of medical instruments and equipment from over 64 manufacturers in 19 countries. This mitigates the risk in the event that any manufacturer experiences business problems that prevent them from selling products to the Company, as the Company can import products from other manufacturers that it represents. In the case where the manufacturer will sell products directly to customers without appointing the Company as a distributor, the Company assesses that the possibility of the manufacturer selling products in Thailand directly is quite low. This is because the manufacturer would have to allocate personnel and incur marketing expenses in Thailand, which is not the business objective of major foreign manufacturers. In the event that a manufacturer terminates the Company's appointment as a distributor, it is often due to the restructuring of the foreign manufacturer, such as acquisitions or mergers. As a result, the manufacturer may not choose the Company as a distributor, depending on the manufacturer's policy. However, if such an event occurs, the Company can negotiate with new manufacturers to sell the same type of products. The Company has also contracted Original Equipment Manufacturers (OEMs) to manufacture products under the Company's own brand, which currently has 14 products. This is to mitigate the risk of not having the distributor agreement renewed. | 737 · Other name: Risks of Being a Medical Device and Equipment Distributor · Description: Other · Info category: STRATEGIC_RISK |
| Industry competition risks and price competition. | The medical device and equipment distributor business in Thailand is highly competitive due to a large number of players. According to BOL Enlite data, as of 2016, there were a total of 14,345 operators in the business, divided into 10,782 micro-enterprises (accounting for 75.2% of the total number of operators), followed by 3,519 SMEs (24.5%), and 44 large operators (0.3%). | Due to a large number of players in the market, combined with the availability of products from other manufacturers or importers of medical instruments and medical devices who sell products under other brands with standards close to the products that the Company distributes, customers may easily choose to use products from other manufacturers or distributors as substitutes. As the government has changed the procurement system in accordance with the Procurement Act B.E. 2560, procurements valued over 500,000 Baht are required to participate in e-bidding. This allows other entrepreneurs to participate in the bidding competition, resulting in more intense price competition. | The company has maintained a strong relationship with manufacturers for a long time, enabling negotiation of favorable prices for bidding on projects. The company closely monitors daily bid announcements and participates in bids for products within its distribution portfolio. Furthermore, the company implements pricing strategies by offering promotions to stimulate sales and attract customers, aiming to maintain or expand its market share. Although medical devices and equipment sold in Thailand encompass a wide range of product types, applications, quality levels, and brands from numerous countries worldwide, the company specializes in the sale of its specific product portfolio. With a customer base primarily composed of leading government and private hospitals in Thailand, the company has been appointed as an exclusive distributor for several products. The company's diverse product range consists mainly of disposable medical devices. Currently, the company's policy focuses on expanding its offerings to include more innovative medical devices to enhance its competitive edge and meet evolving customer demands. This approach ensures the company's continued success in distributing medical devices and equipment in Thailand over the long term. | 1714 · Description: Competition risk · Info category: STRATEGIC_RISK |
| Trade receivable risk | The company distributes products to healthcare facilities in Thailand, including government hospitals, private hospitals, and clinics and medical personnel, with the following collection policies for different customer types: Government hospitals, payment is due within 90 days credit term. Private hospitals, payment is due within 60 - 90 days credit term. Clinics and medical personnel, payment is due in cash or within 30 days credit term. | The company's revenue comes primarily from government hospitals. Many government hospitals often have a history of making payments later than the company's established policy, as they have to wait for budget disbursement from the government. This exposes the company to the risk of late payments from government hospital customers beyond the stipulated timeframe. | Based on the payment history data over the past 3 years, the Company has not experienced any bad debts from collecting payments from government hospital customers or other customer groups. This is because the Company has debt collection officers covering different regions who consistently monitor debt collection. In addition, the Company has a policy of monitoring receivables from customers through the Company's sales representatives. The Company requires sales representatives to fully monitor payments from customers under their responsibility. This gives the Company confidence that the risk of bad debts from late payments from government hospital customers is minimal. | 767 · Other name: Trade receivable risk · Description: Other · Info category: FINANCIAL_RISK |
| Risk of reliance on key personnel in business operations | Currently, the company is managed by its principal executives, Dr. Supapong Chanlongbutra and Mrs. Soonthree Chanlongbutra, who co-founded the company in 2002. Dr. Supapong Chanlongbutra serves as Director, Authorized Director, Chairman of the Executive Committee, President, and holds a 21.429% stake in the company's paid-up capital. Mrs. Soonthree Chanlongbutra serves as Director, Authorized Director, Member of the Executive Committee, Chairman of the Risk Management Committee, Member of the Nomination and Compensation Committee, Chief Executive Officer, and holds a 20.859% stake in the company's paid-up capital. Both possess extensive knowledge, capabilities, and experience in the medical device industry. They are visionary leaders directly responsible for formulating policies, directions, and overseeing the company's core business operations. | If there are changes to the aforementioned directors and executives, the company may experience problems in conducting business in the future. | The Company has adopted a professional management approach, with clear assignments of duties and responsibilities to other executives and employees in each department. To decentralize management and mitigate the risk of relying on both directors in running the business, the Company has structured its organization to appoint qualified and experienced personnel to serve as key executives in various fields according to their expertise. The Company also facilitates regular exchange of necessary information among executives and employees. In addition, the Company has allowed executives at all levels to participate more in decision-making and setting the Company's direction. Management authority is decentralized, and responsibilities for various tasks are clearly defined. Therefore, although Dr. Supapong Chanlongbutra and Mrs. Soonthree Chanlongbutra remain the main policymakers of the Company, key executives in each department have the authority to make decisions and manage various aspects in detail, which can reduce the risk of dependence on the directors and key executives. The Company has established a succession plan to ensure continuity in operations and organizational management. This begins with management positions first, to prepare workforce readiness and personnel potential to effectively assume key positions within the organization, in line with the objectives and to support the sustainable growth of the Company. | 738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK |
| Exchange rate volatility risk | Products sold by the company are mainly imported from abroad, for which quotations and payments are primarily made in US dollars. Meanwhile, products distributed domestically are transacted entirely in Thai Baht. | The company may be exposed to risks from foreign exchange rate fluctuations. When the value of the Thai baht depreciates against the United States dollar, it will result in a higher amount of money the company has to pay for goods. This may consequently increase the company's cost of goods sold. On the other hand, if the Thai baht appreciates, it may lower the company's cost of goods. It will also affect the exchange rate gain (loss) incurred. | To mitigate the risk from foreign exchange rate fluctuations, the company enters into forward contracts (Forward Contract) for every import of goods from abroad. This enables the company to determine the cost of goods sold and hedge against exchange rate volatility that could impact the company's operating results. Entering into forward contracts is at the discretion of the company's management and in accordance with the authority manual approved by the Board of Directors. The company places importance on exchange rates and has established measures to closely monitor and assess exchange rate risk situations. This includes tracking trends and movements in foreign exchange rates, analyzing economic news and information, and analyzing the trend of the Baht against major foreign currencies. | 764 · Description: Fluctuation in exchange rates, interest rates, or the inflation rate · Info category: FINANCIAL_RISK |
| Cybersecurity Risks | Currently, technology plays a crucial role in conducting business. Therefore, the company places great importance on technology system security and electronic data storage to ensure the security of the company's information technology and communication systems from cyber threats that may attack the company's computer systems and potentially cause damage to the systems or data within, | If a cyber threat occurs to the company's ERP operating system, it will cause an operational disruption. Due to the nature of the business as a distributor of medical equipment that receives purchase orders, sends quotations, and prepares a large number of bidding documents each day, including delivering products to customers, the inability to access the system and perform tasks results in significant losses for both the company and customers. | The company has established an information technology security policy to serve as a guideline for controlling, preventing risks, and managing security-related incidents properly. This policy covers network systems, hardware, and software, including server management, network access control, data security, emergency backups, and data recovery. The policy is reviewed annually or when significant changes occur. Establish a cybersecurity unit tasked with developing and maintaining a cybersecurity framework or best practices in line with international standards. The unit will also monitor and comply with cybersecurity laws and regulations at least annually. Develop an incident response plan and a recovery plan. Conduct vulnerability assessments or penetration tests at least once a year. In addition, the company communicates and provides training on cyber threats to raise awareness and understanding of how to deal with threats to employees in the organization at least once a year. Conduct system recovery drills twice a year in the event of a system failure. In the event of a cyber threat, users who witness the incident must report the incident to the administrator as soon as possible. The company provides cybersecurity knowledge to employees in the organization through various training and communication channels to raise awareness within the organization. In 2024, the company organized a "Cyber Security Awareness Interactive Training" for employees, with 40 employees trained, representing 66.67 percent. In addition, the company did not experience any severe cyber threats affecting the company's computer systems and operations. | 744 · Description: Information security and cyber-attack · Info category: OPERATIONAL_RISK |
| Employee retention risk | The company places great importance on human resource management, as employees are one of the most important factors in the sustainable operation of the organization. The company's business is a distributor of medical instruments and medical equipment where contact between customers and the company is conducted through salespeople. Employee turnover therefore affects the company in terms of reduced organizational efficiency and effectiveness. | A high employee turnover rate has a negative impact on the company, both in terms of hiring and training costs. New employees need time to adjust. If they are sales representatives who are responsible for selling and contacting customers, it will cause discontinuity in work, affecting customer service. | The company has practices to retain employees for a long time to reduce the turnover rate, such as surveying compensation and benefits of other companies in the same industry to provide appropriate and fair compensation. Providing benefits to employees, such as social security funds, provident funds, group health insurance, improving the organizational environment, organizing training to develop employee potential, organizing activities to connect employees and the organization, and conducting annual employee satisfaction surveys. | 742 · Description: Human error in business operations · Info category: OPERATIONAL_RISK |
| Personal Data Protection Act (PDPA) Risks | The company's business operations involve the use and storage of personal data of customers, partners, and employees, which may pose a risk of data breaches and adversely affect the company's reputation and image. | Data breaches can occur from various viruses and human negligence. Unauthorized data leakage can negatively impact a company's image and customer trust. | The company recognizes and acknowledges the importance of personal data. To comply with the Personal Data Protection Act B.E. 2562, the company has established a Personal Data Protection Working Group. This group is responsible for establishing policies, guidelines, and practices related to personal data protection. It also oversees, disseminates, and provides training to enhance understanding and knowledge of personal data protection among company employees and external parties. Furthermore, the internal auditor has reviewed the adequacy and effectiveness of the control practices related to the management processes of personal data collection, storage, use, disclosure, and destruction. The review also encompassed the processes of personal data processing, protection, and security. The findings indicate that the company has adequate operational procedures. | 1723 · Description: Legal risk · Info category: COMPLIANCE_RISK |
| Risk of expired or obsolete products | The company operates as a distributor, primarily importing products from overseas. The imported products are diverse in types and applications, with an average lifespan of 1-3 years. | If obsolete inventory occurs, the company must establish an allowance for obsolete inventory, resulting in increased expenses that affect the company's net profit. | The company places importance on inventory management. We have implemented a WMS (Warehouse Management System) to enhance operational efficiency. This enables real-time inventory monitoring and benefits the management of inventory with a shelf life to prevent deterioration or obsolescence. Products nearing their expiration dates will be sold off to minimize losses from expiration and prevent waste. Furthermore, the sales and purchasing departments hold monthly meetings to report and monitor sales performance, including forecasting future sales. This ensures that subsequent purchase orders correlate with the remaining inventory and are sufficient to meet sales demands. In the event that product sales do not meet the set target, resulting in obsolete or expired products, the company will donate the expired products to the Faculty of Medicine of the university. This will be beneficial as a learning and teaching tool for medical personnel. | 743 · Description: Product obsolescence · Info category: OPERATIONAL_RISK |

